Marcela Maus's guest appearances

Marcela Maus

The Hematologist

#ExpertAnswers - an InsideScientific Podcast

Chris Adams

Jason Gardner

Matt Morris

Robert Gould

Caroline Williams

Thomas Smith

Ken Anderson

Rachel Yehuda

Jeff Walker

Andrew Klein

David Anderson

John Waters

James Clark

Matt Robinson

Joanna Moore

OwlTail

This episode of #ExpertAnswers features Dr. Marcela Maus, Director of Cellular Immunotherapy at Mass General Cancer Center and Associate Professor of Medicine at Harvard Medical School. Dr. Maus recently joined us for a webinar about engineering T cells for cancer where she discussed the components and technologies used in making a  T cell product, important factors that contribute to their efficacy, and underlying mechanisms of toxicity and resistance.For more information or to watch the webinar, click here.

This episode of #ExpertAnswers features Dr. Marcela Maus, Director of Cellular Immunotherapy at Mass General Cancer Center and Associate Professor of Medicine at Harvard Medical School. Dr. Maus recently joined us for a webinar about engineering T cells for cancer where she discussed the components and technologies used in making a  T cell product, important factors that contribute to their efficacy, and underlying mechanisms of toxicity and resistance. For more information or to watch the webinar, <a href="https://insidescientific.com/webinar/engineered-t-cells-for-cancer/" rel="nofollow" target="_blank">click here</a>.

#ExpertAnswers: Marcela Maus on Inflammation and Immunophysiology

Caron Jacobson

In this podcast, Contributing Editor Dr. Caron Jacobson and Dr. Marcela Maus both of Dana Farber Cancer Institute have a thought provoking conversation. They discuss Dr. Jacobson's Diffusion article from the May/June 2018 issue of The Hematologist. The article titled, "In Vivo and In-stantaneous Production of Chimeric Antigen Receptor T Cells: Overcoming Treatment Delays" talks about the in vivo and instantaneous production of chimeric antigen receptor T cells as a way to overcome potentially rate-limiting manufacturing times needed for current ex vivo technologies. You can find the Diffusion article online at www.hematology.org/Thehematologist/Diffusion/8464.aspx.Music: "Jellyfish in Space" Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

In this podcast, Contributing Editor Dr. Caron Jacobson and Dr. Marcela Maus both of Dana Farber Cancer Institute have a thought provoking conversation. They discuss Dr. Jacobson's Diffusion article from the May/June 2018 issue of The Hematologist. The article titled, "In Vivo and In-stantaneous Production of Chimeric Antigen Receptor T Cells: Overcoming Treatment Delays" talks about the in vivo and instantaneous production of chimeric antigen receptor T cells as a way to overcome potentially rate-limiting manufacturing times needed for current ex vivo technologies. You can find the Diffusion article online at <a href="http://www.hematology.org/Thehematologist/Diffusion/8464.aspx" rel="nofollow" target="_blank">www.hematology.org/Thehematologist/Diffusion/8464.aspx</a>. Music: "Jellyfish in Space" Kevin MacLeod (<a href="http://incompetech.com" rel="nofollow" target="_blank">incompetech.com</a>). Licensed under Creative Commons: By Attribution 3.0 <a href="http://creativecommons.org/licenses/by/3.0/" rel="nofollow" target="_blank">creativecommons.org/licenses/by/3.0/</a>

In Vivo and In-stantaneous Production of CAR T Cells With Drs. Caron Jacobson and Marcela Maus